Männedorf, Switzerland – Tecan Group (SIX Swiss Exchange: TECN) today announced that Tania Micki, Chief Financial Officer and member of the Management Board since February 2020, will be leaving the company to pursue an external opportunity. She will continue in her role through May 2026 to ensure a smooth transition. Tecan will nominate her successor […]

Biotium’s new TyraMax™ Amplification Dyes and Kits are available with the widest selection of colors for spatial analysis. FREMONT, CA — Biotium, a leading innovator in life science reagents, is excited to introduce TyraMax™ Amplification Dyes and Kits. Designed for superior brightness, photostability, and stability in amplification buffer compared to competitor reagents, TyraMax™ dyes deliver […]

Regulatory milestone enables single cell sequencing to enter routine clinical diagnostics COLOGNE, GERMANY –  Singleron Biotechnologies announced today that its Matrix NEO™ automated single cell processing system has received Class II Medical Device Registration approval from the Jiangsu Medical Products Administration, China (Registration No.: 20252222135). Matrix NEO is the world’s first automated single cell analysis platform to achieve medical […]

Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE — Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (NHCS) to accelerate innovation in metabolic heart failure research, one of the most […]

MARKHAM, Ontario — Alpha Controls & Instrumentation Inc. (“Alpha Controls”), a leading Canadian distributor of instrumentation and provider of calibration, validation and process-control solutions, is pleased to welcome Hamilton to its supplier network, reinforcing the company’s commitment to delivering world-class laboratory equipment, analytical instruments, and bioprocess monitoring solutions to the Canadian market. As Alpha Controls continues to expand […]

MOUNT PLEASANT, SC, UNITED STATES — Efferent Labs, an innovator in real-time biosensor systems that enable continuous biological monitoring, has announced the appointment of Philip D. Manos as Chief Science Officer. The company’s breakthrough technology could dramatically reduce reliance on animal testing and transform how drugs are discovered and diseases are monitored. Manos will lead the scientific […]

Patent strengthens 3D Ready™ portfolio, enabling consistent, assay-ready organoids for predictive drug discovery SAN JOSE, Calif. – Molecular Devices, LLC., a leading provider of high-performance life science solutions, today announced the issuance of U.S. Patent No. 12,351,820 B2, titled “Methods for Culturing Organoids.” The patent covers aspects of the company’s novel bioreactor-based method for producing organoids. Molecular Devices’ […]

Kit offers novel protein interactomics analysis of immune cells MORRISVILLE, N.C. and STOCKHOLM — Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced today a partnership to expand access to cutting-edge 3D protein interactomics capabilities to researchers and clinicians in the United States. Carolina Molecular will be the first certified U.S. service provider for […]

Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. CAMBRIDGE, Mass. and SAN DIEGO, Calif. — Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the two […]

Company initiates search for successor ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Chief Financial Officer Douglas Swirsky has informed the Company of his decision to transition from his role in the first […]